Skip to content

Redmond Smyth

  • B.A. (Hons), M.A. (Cantab), Ph.D.
  • Group Leader
  • Helmholtz Institute for RNA-based Infection Research (HIRI), Würzburg, Germany
  • 11h-indexImpact measure calculated using publication and citation counts. Updated daily.
  • 409CitationsNumber of citations received by Redmond's publications. Updated daily.

Editorships

Frontiers in Cellular and Infection Biology

Review Editor

2018 - Present

Virology Journal

Associate Editor

2016 - Present

Recent publications

  • In cell mutational interference mapping experiment (in cell MIME) identifies the 5′ polyadenylation signal as a dual regulator of HIV-1 genomic RNA production and packaging

    • Smyth R
    • Smith M
    • Jousset A
    • et al.
    N/AReaders
    N/ACitations
    Get full text
  • RNA Structure—A Neglected Puppet Master for the Evolution of Virus and Host Immunity

    • Smyth R
    • Negroni M
    • Lever A
    • et al.
    N/AReaders
    N/ACitations
    Get full text

Professional experience

Group Leader

Helmholtz Institute for RNA-based Infection Research (HIRI), Würzburg, Germany

May 2018 - Present

Associate Professor

Julius Maximilians University, Würzburg, Germany

May 2018 - Present

Chargé de Recherche

IBMC-CNRS, Strasbourg, France

November 2015 - April 2018(2 years)

Postdoctoral Researcher

IBMC-CNRS, Strasbourg, France

April 2011 - September 2015(4 years)

Postdoctoral Research Officer

Burnet Institute, Melbourne, Australia

February 2011 - March 2011(a month)

PhD Student

The Burnet Institute, Melbourne, Australia

May 2005 - October 2010(5 years)

Education

PhD

Department of Biochemistry and Molecular Biology, Monash University, Melbourne, Australia

May 2005 - March 2010(5 years)

BA

University of Cambridge, United Kingdom

October 2000 - June 2003(3 years)

Research interests

InfluenzaRNAviral assemblynext generation sequencingHIV

About

My group studies the structure and function of non-coding RNA within viral genomes, with the goal of harnessing the resulting knowledge in the design of next generation RNA-based therapies.

Co-authors (72)

  • David Hawkes
  • Fathima Nuzra
  • Dave Hawkes
  • Kate Jones